Release Date: 05/09/16 17:58 Summary: Director Appointment/Resignation-SWE.AX Price Sensitive: No Download Document 503.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%